FDA Approvals Provide New Advances Against Bladder, Lung, and Kidney Cancer
During late March and early April, the U.S. Food and Drug Administration (FDA) made several decisions that have increased...
During late March and early April, the U.S. Food and Drug Administration (FDA) made several decisions that have increased...
This time last year there were no immune checkpoint inhibitors approved by the U.S. Food and Drug Administration (FDA)...
Earlier this week, the U.S. Food and Drug Administration (FDA) announced that it had approved a new immune checkpoint...
Last week, the U.S. Food and Drug Administration (FDA) announced that it had approved expanding the use of the...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of cancer types for which immunotherapeutics known...
Bladder cancer is the fifth most common cancer in the United States, predominantly affecting men in the later decades...